We are live on ! Find out more
HF

HRT Financial Portfolio holdings

AUM $40.1B
1-Year Est. Return 58.22%
This Fund
S&P 500
This Quarter Est. Return
+7.78%
1 Year Est. Return
+58.22%
3 Year Est. Return
+133.11%
5 Year Est. Return
+158.39%
10 Year Est. Return
+582.81%
AUM
$10.7B
AUM Growth
+$2.5B
Cap. Flow
+$2B
Cap. Flow %
18.71%
Top 10 Hldgs %
43.17%
Holding
3,695
New
1,259
Increased
473
Reduced
526
Closed
1,295

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$136M
2
LIN icon
Linde
LIN
+$111M
3
VLO icon
Valero Energy
VLO
+$106M
4
PANW icon
Palo Alto Networks
PANW
+$105M
5
LMT icon
Lockheed Martin
LMT
+$104M

Sector Composition

Rank Sector Weight
1 Technology 8.52%
2 Consumer Discretionary 7.25%
3 Industrials 6.98%
4 Financials 6.35%
5 Healthcare 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUUD
2126
Auddia
AUUD
$5.1M
$15K ﹤0.01%
+12
New +$19.6K
HYMC icon
2127
Hycroft Mining Holding Corp
HYMC
$2.22B
$15K ﹤0.01%
+5,319
New +$20.1K
NEXR
2128
Nexera Technologies Ltd
NEXR
$1.41M
0
YYAI icon
2129
AiRWA Inc
YYAI
$84K
0
CURO
2130
DELISTED
CURO Group Holdings Corp.
CURO
$15K ﹤0.01%
+11,297
New +$17.3K
SRTAW
2131
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
$14K ﹤0.01%
21,120
-8,454
-29% -$3.78K
CLEU
2132
DELISTED
China Liberal Education Holdings
CLEU
$14K ﹤0.01%
+1
New +$14.1K
GGROW
2133
Gogoro Inc Warrant
GGROW
$187K
$14K ﹤0.01%
34,820
GSUN icon
2134
Golden Sun Technology Group
GSUN
$5.41M
$14K ﹤0.01%
+1,325
New +$16K
LUCY icon
2135
Innovative Eyewear
LUCY
$6.19M
$14K ﹤0.01%
+817
New +$35.4K
NDRA icon
2136
ENDRA Life Sciences
NDRA
$5.81M
$14K ﹤0.01%
+6
New +$16.9K
QBTS.WS
2137
DELISTED
D-Wave Quantum Inc Warrants
QBTS.WS
$14K ﹤0.01%
76,712
RVP icon
2138
Retractable Technologies
RVP
$20.3M
$14K ﹤0.01%
+12,930
New +$18.5K
SKYH.WS icon
2139
Sky Harbour Group Warrants
SKYH.WS
$20.7M
$14K ﹤0.01%
47,756
TONX
2140
TON Strategy Co
TONX
$161M
$14K ﹤0.01%
+66
New +$28.1K
BODI icon
2141
The Beachbody Company
BODI
$72.3M
$14K ﹤0.01%
698
+277
+66% +$6.38K
LSB
2142
DELISTED
LakeShore Biopharma
LSB
$14K ﹤0.01%
+1,050
New +$15.5K
GRND.WS
2143
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$14K ﹤0.01%
20,331
-100
-0.5% -$75
TCON
2144
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$14K ﹤0.01%
+2,458
New +$44.9K
IDEX
2145
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$14K ﹤0.01%
1,513
+840
+125% +$6.45K
GOGN.WS
2146
DELISTED
GoGreen Investments Corporation Redeemable Warrants
GOGN.WS
$14K ﹤0.01%
15,000
BBAI.WS icon
2147
BigBear.ai Holdings Warrant
BBAI.WS
$40.9M
$13K ﹤0.01%
61,069
CTRM icon
2148
Castor Maritime
CTRM
$20.2M
$13K ﹤0.01%
+2,901
New +$17.5K
SONN
2149
DELISTED
Sonnet BioTherapeutics
SONN
$13K ﹤0.01%
+156
New +$11K
TMCWW
2150
TMC The Metals Company Warrants
TMCWW
$428K
$13K ﹤0.01%
68,998

Similar funds

HRT Financial's Q2 2023 Portfolio in Review

As of Q2 2023, HRT Financial held 3,695 positions worth $10.7B, up 30% from $8.2B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

HRT Financial deployed $2B of net new capital in Q2 2023, opening 1,259 new positions and adding to 473 existing holdings. Its largest new stake was Blackstone: 1,401,378 shares worth $130M.

By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Eli Lilly, an estimated $136M trimmed.

  • HRT Financial's largest Q2 2023 buy was Blackstone: 1,401,378 shares worth $130M.
  • HRT Financial added most to State Street SPDR S&P 500 ETF Trust in Q2 2023, an estimated $2.08B increase.
  • HRT Financial's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $136M.
  • HRT Financial fully exited Palo Alto Networks in Q2 2023, selling an estimated $105M.
  • HRT Financial's ten largest holdings make up 43% of its $10.7B portfolio in Q2 2023.
  • HRT Financial opened 1,259 new positions and closed 1,295 in Q2 2023.
  • HRT Financial's portfolio value rose 30% quarter-over-quarter to $10.7B.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.